Combined VEGFR and MAPK pathway inhibition in angiosarcoma

Angiosarcoma is an aggressive malignancy of endothelial cells that carries a high mortality rate. Cytotoxic chemotherapy can elicit clinical responses, but the duration of response is limited. Sequencing reveals multiple mutations in angiogenesis pathways in angiosarcomas, particularly in vascular e...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Michael J., Lyons, Yasmin A., Siedel, Jean H., Dood, Robert, Nagaraja, Archana S., Haemmerle, Monika, Mangala, Lingegowda S., Chanana, Pritha, Lazar, Alexander J., Wang, Wei-Lien, Ravi, Vinod, Holland, Eric C., Sood, Anil K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087824/
https://www.ncbi.nlm.nih.gov/pubmed/33931674
http://dx.doi.org/10.1038/s41598-021-88703-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087824/
https://www.ncbi.nlm.nih.gov/pubmed/33931674
http://dx.doi.org/10.1038/s41598-021-88703-9

Ejemplares similares